Bank of Montreal’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRA
WA
BG
MC
RG
Bank of Montreal's ATRA Position: Q3 2022 in Review
Bank of Montreal sold out of Atara Biotherapeutics (ATRA) in Q3 2022, closing a stake of 6,152 shares — an estimated $1.09K sold.
Bank of Montreal first reported a position in ATRA in Q1 2016 and held it in 18 quarters. The position peaked at $1.55M in Q1 2021. 154 funds tracked by Wall St. Rank hold ATRA as of Q3 2022.
- Bank of Montreal reported no remaining Atara Biotherapeutics position as of Q3 2022 after selling out during the quarter.
- Bank of Montreal sold 6,152 Atara Biotherapeutics shares in Q3 2022, an estimated $1.09K.
- Bank of Montreal first reported a position in Atara Biotherapeutics in Q1 2016 and held it in 18 quarters.
- Bank of Montreal's Atara Biotherapeutics position peaked at $1.55M in Q1 2021.
- 154 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2022.
Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.